2 months ago
Base Salary
$180k - $215k/yr
Responsibilities
- Define technical roadmaps, migration patterns, and reference architectures for moving AWS Lambda functions and ECS services to Kubernetes on AWS EKS.
- Design, implement, and govern scalable event-driven, serverless-like workflows on Kubernetes.
- Build and manage Kubernetes infrastructure, networking, and deployment tooling with Terraform, Terragrunt, and Helm.
- Partner with engineering teams to assess workloads, advise on re-platforming, and develop standardized migration and deployment tools.
- Benchmark migrated services, optimize resource requests and limits, and implement monitoring, logging, and tracing solutions.
- Establish operational best practices, guardrails, and documentation for event-based compute on Kubernetes.
Requirements
- 8+ years of experience in platform, infrastructure, or DevOps engineering, including significant large-scale compute migration experience.
- Expert-level proficiency in Kubernetes design, deployment, operations, networking, security, and scaling.
- Deep hands-on experience with AWS compute services, especially AWS Lambda and ECS/Fargate.
- Proven experience migrating production workloads from VMs, Lambda, or ECS to Kubernetes.
- Strong Infrastructure as Code experience, specifically with Terraform.
- Proficiency with Docker and modern CI/CD practices.
- Strong communication, documentation, and technical leadership skills with the ability to influence decisions across teams.
- Experience with KEDA or similar Kubernetes event-driven scaling solutions is preferred.
- Experience working in or migrating to a monorepo is preferred.
- Experience leading complex, multi-quarter technical initiatives is preferred.
- Experience with Python or Go for tooling development and automation is preferred.
Benefits
- Hybrid work arrangement.
- Base salary range of $180,000 to $215,000, plus bonus and equity.
About Heartflow
HeartFlow develops an AI-driven, non-invasive coronary care platform that converts coronary CT scans into 3D models and physiologic assessments (FFRct), sold to hospitals and cardiology practices. Its HeartFlow One suite (including RoadMap, FFRct, and Plaque Analysis) supports diagnosis and management of coronary artery disease and is cleared for use in the US, UK, Europe, Japan, and Canada. The company is headquartered in San Francisco and is publicly traded on Nasdaq under the ticker HTFL.